
CIAã®å éšåçºè ïŒãã¡ãŠãæ°ãCOVIDã®ç ç©¶ææµåºã®èšŒæ ã倿©é¢ã§é èœäž»å°
å èšäºã¯ãã¡ããã/Click here to read the original article.
ããã¡ãŠãå士ã®é èœãžã®é¢äžã¯æå³çã§ããããšCIAã®äžçŽäœæŠæ åœå®ãžã§ãŒã ãºã»Eã»ã¢ãŒããã³äžäžã¯è¿°ã¹ããã¢ãŒããã³æ°ã¯ãã©ã³ãã»ããŒã«äžé¢è°å¡ãå§å¡é·ãåããäžé¢åœåå®å šä¿éã»æ¿åºåé¡å§å¡äŒãäž»å¬ããå ¬èŽäŒã§èšŒèšãããã¢ãŒããã³æ°ã¯ãé èœã¯çŸåšãç¶ããŠãããCIAã®å éšåçºè ãã¡ãæ©é¢ããã®å ±åŸ©ã«çŽé¢ããŠãããšè¿°ã¹ãã
CIAã®å éšåçºè ãæ¬æ¥ãç±³äžé¢ã§ãã¢ã³ãœããŒã»ãã¡ãŠãå士ããCOVID-19ãç±³åœã®è³éæäŸãåããç§åŠè ãã¡ãšååããŠããäžåœã®ç ç©¶æããçºçããããšã瀺ã蚌æ ã®é èœã«ãæå³çã«å æ ãããšèšŒèšããââãã®ç§åŠè ã®äžéšã¯ããã³ãããã¯ã®æ°ã«æåããæ©èœç²åŸç ç©¶ãã³ãããŠã€ã«ã¹ã«é¢äžããŠããã
ããã¡ãŠãå士ã®é èœãžã®é¢äžã¯æå³çã§ããããšèªã£ãã®ã¯ãCIAã®äžçŽäœæŠæ åœå®ãžã§ãŒã ãºã»Eã»ã¢ãŒããã³äžäžãã¢ãŒããã³ã¯ãã©ã³ãã»ããŒã«äžé¢è°å¡ïŒå ±åå ã»ã±ã³ã¿ãããŒå·ïŒãå§å¡é·ãåããäžé¢åœåå®å šä¿éã»æ¿åºæŽ»åå§å¡äŒãäž»å¬ããå ¬èŽäŒã§èšŒèšããã
ã¢ãŒããã³ã¯ã2025幎3æãã2026幎4æãŸã§é£éŠæ¿åºã®ãã£ã¬ã¯ã¿ãŒãºã»ã€ãã·ã¢ãããºã»ã°ã«ãŒãïŒDIGïŒã«æå±ããCOVID-19ã®èµ·æºèª¿æ»ãäž»å°ããããã®è·åã«ããããã¡ãŠããCIAããããŠç±³åœã®æ å ±ã³ãã¥ããã£ã®ä»ã®èŠçŽ ããCOVID-19ã®ç ç©¶ææµåºã®èšŒæ ãç©æ¥µçã«é èœããŠãããšãã蚌æ ã«è§Šãããšè¿°ã¹ãã
圌ã«ããã°ãé èœã«ã¯ãå°ããªèŒªãã®ç§åŠè ãé¢äžããSARS-CoV-2ãŠã€ã«ã¹ã¯äººç£å ±éææçãããªãã¡èªç¶èµ·æºã ãšããèª¬ã®æšé²ã«äžåœ¹è²·ã£ããããã«ãã¡ãŠãã¯ããŠã€ã«ã¹ã®èµ·æºã«é¢ããçåºæšªæã®èª¿æ»ãäž»å°ããŠããç±³åœã®åæ å ±æ©é¢ã®ææ»å®ãã¡ããåãç§åŠè ãã¡ã«ç޹ä»ãããšããã
ã¢ãŒããã³ã¯ããããã®ç§åŠè ãããŠã€ã«ã¹ã®æ¯æ§ãææåãé«ããã¯ã¯ãã³éçºã§ãçšããããæ©èœç²åŸç ç©¶ã«é¢ä¿ããŠãããšè¿°ã¹ãã
ã¢ãŒããã³ã¯ãé èœã¯çŸåšãç¶ããŠãããCIAã®å éšåçºè ã¯æ©é¢ããã®å ±åŸ©ã«çŽé¢ããŠãããšè¿°ã¹ããCOVID-19ã®èµ·æºã«é¢ãããã¹ãŠã®ææžã®æ©å¯è§£é€ãæ±ããæ³åŸã«åŸãããšã«å¯ŸããŠCIAå ã«äŸç¶ãšããŠæµæãããã®ããšåããããšãã¢ãŒããã³ã¯ãã¯ãããšçããã
ã¢ãŒããã³ã¯è°å¡ãã«å¯Ÿããå ¬è¡è¡çæ¿çã¯ãããã¢ã¡ãªã«åœæ°ããäžåœã®ç ç©¶æããã®ãŠã€ã«ã¹ããåæ¿æš©ã«ãã矩ååãããããšã«ãªã£ãç·æ¥äœ¿çšèš±å¯ã®mRNA補åã®åå°ã«ãªããšç¥ããããŠããã°ããŸã£ããéã£ããã®ã«ãªã£ãŠããã¯ãã ããšè¿°ã¹ãã
ããŒã«ã¯COVID-19ã®ãã³ãããã¯ããæã ã®çæ¶¯ã§æãé倧ãªåºæ¥äºã®äžã€ããšåŒãã ãåäžé¢è°å¡ã¯ãã仿¥ã«è³ããŸã§ãç±³åœæ°ã¯ãïŒãŠã€ã«ã¹ãïŒã©ãããæ¥ãã®ããæ¿åºãäœãç¥ã£ãŠããã®ãããããŠãªãççžãç¥ãããã«èªåãã¡ã®æ¿åºãšæŠããã°ãªããªãã£ãã®ããã«ã€ããŠå®å šãªèª¬æãåããŠããªãããšèªã£ãã
ãã«ãã¬ã³ãºã»ãã«ã¹ã»ãã£ãã§ã³ã¹ã®CEOã§ããã¡ã¢ãªãŒã»ãã©ã³ãã¯ãæ¬æ¥ã®å ¬èŽäŒãã6幎以äžã«ãããè°äŒã絡ãåã£ãŠããCOVID-19ã®åªçžãè§£ããããšè¿°ã¹ãã
ãã€ãã«ãè°äŒããCOVID-19ã®å¹Žæã«ããæ»ãšç Žå£ã®è²¬ä»»ãåãããã«ãåå®ã«å¿ èŠãšãããŠããç·æ±ºç®ã«çæããã®ã§ã¯ãªãããšæããããšãã©ã³ãã¯èªã£ãã
ã¢ãŒããã³ã¯ãCOVID-19ã®èµ·æºã«é¢ããããŒã«ã®ç¶ç¶çãªèª¿æ»ã®äžç°ãšããŠã仿åãã«äžé¢å§å¡äŒãçºè¡ããå¬åç¶ã«å¿ããŠæ¬æ¥èšŒèšããã
CIAã¯ã¢ãŒããã³ã®èšŒèšãæ¿èªããªãã£ããæ¬æ¥ã®å ¬èŽäŒã«ã¯äžé¢æ°äž»å è°å¡ã¯èª°ãåºåžãããåå ãããªãã£ãââãã©ã³ãã¯ãã®æ¬ åžããåŒè§£ã®äœå°ããªãããšè©ããã
ãã®åŸãæ¬æ¥äžã«ãã©ãã¯ã¹ã»ãã¥ãŒã¹ã¯ãCIAãæ¬æ¥ã®å ¬èŽäŒã«ãäžå¿«æã瀺ããããšå ±ããã
JUST IN: Tensions flare between the CIA and Sen. Rand Paul over a COVID-19 whistleblower hearing.
â Fox News (@FoxNews) May 13, 2026
The agency is reportedly ânot happy,â accusing Paul of acting in bad faith as he pushes forward with testimony tied to the virusâs origins.
Paul fires back, telling @BillMelugin_⊠pic.twitter.com/uSaKpeqsDH
ããã³ãããã¯ã®åœåããããã¡ãŠãå士ãçµè«ãæ¹åã¥ããŠããã
ãšã¢ããã³æ°ã«ãããšããã¡ãŠãæ°ã¯2020幎ãš2021幎ã«è€æ°åãæ©é¢æšªæã®èª¿æ»æ åœè ãšé¢äŒãããåœæãã§ã«CIAã¯ããŠã€ã«ã¹ãç ç©¶æããæŒããããå¯èœæ§ãåŒ·ãæ€èšããŠãããèª¿æ»æ åœè ã¯ãã¡ãŠãæ°ãšè©±ããããã£ãŠããããã¡ãŠãæ°ã¯ã粟éžããããŒãå¥ã®å°éå®¶ãªã¹ããã圌ãã«æäŸãããšããã
ãããããã®å°éå®¶ãªã¹ãã¯ãå¶ç¶ã«ããã2020幎ã®éèŠãªNature Medicineè«æãSARS-CoV-2ã®è¿çžèµ·æºïŒThe proximal origin of SARS-CoV-2ïŒãã®å ±èè äžèЧãšäžèŽããŠãããåŸã«ãã¡ãŠãæ°ãä»ã®å ¬è¡è¡çåœå±è ãã¡ãã£ã¢é¢ä¿è ã¯ããã®è«æãçšããŠç ç©¶æèµ·æºèª¬ãéãããã®æå±è ããé°è¬è«è ããšããŠå€±å¢ãããã
ããã¡ãŠãæ°ã«ãã£ãŠãç©èªïŒãã©ãã£ãïŒããäœãããŠããã®ã§ãããšãšã¢ããã³æ°ã¯è¿°ã¹ãã
æšå¹Žããã©ã³ãæ¿æš©ã¯ããã¡ãŠãæ°ããè³éæäŸãšåŒãæãã«åè«æã®çµè«ã«åœ±é¿ãäžãããã©ããã調ã¹ã調æ»ãéå§ããã
ãšã¢ããã³æ°ã¯ã2021幎8æã«ãã¡ãŠãæ°ã®ä»å ¥ããCOVID-19ã®èµ·æºã«ã€ããŠCIAãç ç©¶ææŒããèª¬ãæ¯æããã®ã§ã¯ãªãäžç«çç«å Žãæ¡çšããããšã«ã€ãªãã£ããšèšŒèšããã圌ã¯ããè¿°ã¹ãã
ãã¢ã³ãœããŒã»ãã¡ãŠãæ°ãæ å ±ã³ãã¥ããã£ïŒICïŒã«èªãé¢äžããããšããé倧ãªåœ±é¿ãåãŒããŸããã⊠æã ã®æå ã«ã¯ãCIAãå°ãªããšã2021幎8æ12æ¥ã®æç¹ã§ããããç ç©¶æããã®æŒãããšåŒã¶ããšãæ€èšããŠããããšãç€ºãææžããããŸãããšããããããã2021幎8æ17æ¥ã«å€ãããŸããã⊠æ®å¿µãªãããCIAã¯æã ãæ±ããææžãæäŸããªãã£ãããããªãå€ãã£ãã®ãã¯å šãåãããŸãããã
ãã®1é±éãçµããªããã¡ã«ãç±³é£åå»è¬åå±ïŒFDAïŒã¯ãã¡ã€ã¶ãŒã®mRNAã¯ã¯ãã³ãã³ãããã£ïŒComirnatyïŒãã«å®å šæ¿èªãäžãããFDAãæ¿èªãåºããç¿æ¥ãç±³è»ã¯éå¡ãžã®ã¯ã¯ãã³æ¥çš®ã矩ååããã
ãšã¢ããã³æ°ã¯ããã¡ãŠãæ°ãä»ã®åœå±è ãé èœã«ã€ããŠå ¬ç¶ãšè°è«ããããšã瀺ããæ±ºå®ç蚌æ ïŒã¹ã¢ãŒãã³ã°ã»ã¬ã³ïŒãã®ææžã¯èŠã€ãã£ãŠããªããã®ã®ã圌ãç®ã«ããå€ãã®ææžã«ã¯ããã瀺åãããåºç¯ãªåºæµãããã£ããšè¿°ã¹ãã
ããã³ãããã¯ã®åœåããããã¡ãŠãå士ãçµè«ã圢äœã£ãŠããŸããããšããŒã«æ°ã¯è¿°ã¹ããã圌ã¯ããã³ãããã¯ãç ç©¶æã«èµ·æºãæã€ãšããèãããäœååãé°è¬è«ã ãšè©ããŸãããã
âFrom the outset of the pandemic, Dr. Fauci shaped the conclusions.â
â CHDTV Live (@CHDTVLive) May 13, 2026
According to testimony shared by Sen. Rand Paul, scientists privately raised lab leak concerns â then publicly dismissed them.
One author of the The Proximal Origin of SARS-CoV-2 paper reportedly received a $9⊠pic.twitter.com/t5FXlgX25a
ã¢ãŒããã³ã«ããã°ããã¡ãŠãã®èŠè§£ã¯å€ãã£ãŠããªããã圌ã¯èªç¶èµ·æºã ãšä¿¡ããŠããŸããä»ãããã§ãããšã¢ãŒããã³ã¯è¿°ã¹ãã
CIAãCOVIDã®å éšåçºè ããéæ³ã«ãã¹ãã€
ã¢ãŒããã³ã¯ãé èœã®å¯èœæ§ã«ã€ããŠçºèšããCIAè·å¡ããç£èŠããå ±åŸ©ã«è³ããŸã§ã®åœ±é¿ãæ©é¢ããåããŠãããšèšŒèšããã
ã2023幎ã«è³ãCIAã®COVID忀èšã®åŸãç ç©¶ææµåºä»®èª¬ãæ¯æããåæå®ã«å¯ŸããCIAã¯å ±åŸ©ããŸããããšã¢ãŒããã³ã¯è¿°ã¹ãããCIAã®ç®¡çè·ã¯ãåæã®æ·±å€ã®å¿åã®æžãæãã«åæããããšãæãã 圌ãã«å ±åŸ©ããŸããããã®æžãæãã«ãããè©äŸ¡ã¯çµè«ã瀺ããªã倿ãžãšå€æŽãããŸãããã
ã¢ãŒããã³ã«ããã°ãCIAã¯DIGè·å¡ã®ãã³ã³ãã¥ãŒã¿ãŒããã³é»è©±ã®äœ¿çšç¶æ³ããéæ³ã«ç£èŠãå§ããããã«ã¯ã圌ãã®èª¿æ»ãå éšåçºè ãšã®é£çµ¡ããå«ãŸããŠããã
ããããã¯ã倧統é ã®æç€ºã«åºã¥ããåœå®¶æ å ±é·å®ã®æš©éäžã§è·åãéè¡ããŠããæäžã«ãéæ³ã«ã¹ãã€ãããŠããã¢ã¡ãªã«äººã§ããããšã¢ãŒããã³ã¯è¿°ã¹ããå°ãªããšã1åã®CIAå¥çŽè·å¡ããã®çµæãšããŠè§£éããããDIGãšã®é¢äŒã®ç¿æ¥ã«ãè·ã倱ã£ãã
ã¢ãŒããã³ã¯ãããã®çš®ã®è¡çºãæ¯æ£ãããªãéããç«æ³åºãšè¡æ¿åºã¯èª€ã£ãæ å ±ã«åºã¥ãç¶æ ãç¶ãã ãããšè¿°ã¹ãã
å ¬èŽäŒã«åå ããè€æ°ã®å ±åå äžé¢è°å¡ã¯ãããŸããŸãªæ¿åºæ©é¢ãæ å ±æ©é¢ãçŸåšãCOVID-19ã®ç ç©¶ææµåºã®èšŒæ ãé èœããããšããåãçµã¿ã«é¢äžããŠããããšããã¢ãŒããã³ã®ç€ºåã«åæããã
ãã³ã»ãžã§ã³ãœã³äžé¢è°å¡ïŒå ±åã»ãŠã£ã¹ã³ã³ã·ã³ïŒã¯ãå æãFDAãã¯ã¯ãã³æ¥çš®åŸã®çªç¶æ»ãå«ãCOVID-19ã¯ã¯ãã³å®å šæ§ã·ã°ãã«ãããé©åã«æ€åºããæ¹æ³ãææ¡ããŠããã®ã«é ããŠããããšã瀺ã蚌æ ãæç€ºããå ¬èŽäŒãäž»å°ããããè€æ°ã®æ©é¢ã«ãããããŠæ£åœãªç£ç£äžã®èŠè«ããéã£ããã®ã®ã倧åã¯ç¡èŠããããšè¿°ã¹ãã
ãžã§ã·ã¥ã»ããŒãªãŒäžé¢è°å¡ïŒå ±åã»ããºãŒãªïŒã¯ã2023幎ã«åœŒãæåºããè°äŒãå šäŒäžèŽã§å¯æ±ºãããç±³æ¿åºã«COVID-19ã®èµ·æºã«é¢ããææžå ¬éãæ±ããæ³æ¡ã®æç«åŸãæ¿åºã¯å€§åã®ææžããæå³çã«ãéå ¬éã«ãããšè¿°ã¹ãã
èŠè«ã©ããæ°åããŒãžã®ææžãæäŸãã代ããã«ãè°äŒãåãåã£ãã®ã¯äžéšã墚å¡ãããã5ããŒãžã®ã¿ã ã£ããããããé èœã§ãªããšãããªããç§ã«ã¯ããããŸããããšããŒãªãŒã¯è¿°ã¹ãã
æ©èœç²åŸç ç©¶ã®ç£ç£ã«ã¯ãå®å¹æ§ãå¿ èŠã ã
ã¢ãŒããã³æ°ã¯æ©èœç²åŸïŒgain-of-functionïŒç ç©¶ã«ãçå ãåãããåæ°ã«ããã°ãé£éŠã®çç©ç§åŠå°éå®¶ã°ã«ãŒãïŒBSEGïŒã®ç§åŠè ãã¡ãã2014幎ã«çºå¹ããæ©èœç²åŸç ç©¶ãžã®è³éæäŸäžæåæ¢ïŒã¢ã©ããªã¢ã ïŒãèŠãã®ã«å¯äžãããšããã
ãBSEGã®ç§åŠè ã®æ°åã¯ã2015幎ã«ãã¡ãŠãå士ãšãšãã«æ©èœç²åŸã®å®çŸ©ãæžãæããå±éºãªç ç©¶ãžã®è³éæäŸåæ¢ãè§£é€ããã®ãå©ããŸããããšã¢ãŒããã³æ°ã¯èšŒèšãããåæ°ã¯ãBSEGã®ã¡ã³ããŒã¯ããã°ãã°NIAID米åœåœç«ã¢ã¬ã«ã®ãŒææçç ç©¶æïŒœãå ¬è¡è¡çæ©é¢ããå€é¡ã®è³éæäŸãåããŠããããšè¿°ã¹ãã
BSEGã«åå ããŠããç§åŠè ã«ã¯ãæŠæŒ¢ãŠã€ã«ã¹ç ç©¶æã®ç ç©¶è ã§ããç³æ£éºïŒShi ZhengliïŒå士ãšãšãã«æ©èœç²åŸå®éšã«åãçµãã ã©ã«ãã»ããªãã¯ïŒRalph BaricïŒå士ãå«ãŸããŠãããšãã¢ãŒããã³æ°ã¯è¿°ã¹ãããã¶ãã¯æ°ã¯ãã®åŸããWHOïŒäžçä¿å¥æ©é¢ïŒãšãšãã«COVIDã®èµ·æºã調æ»ããããã«äžåœãžæŽŸé£ããããã
å æãããªãã¯æ°ã¯ç±³åœç«è¡çç ç©¶æïŒNIHïŒã®å©æéã倱ããæå±æ©é¢ã§ããããŒã¹ã«ãã©ã€ã倧åŠããåè·åŠåãåãããšå ±ããããã2024幎ã«ã¯ãç±³åœä¿å¥çŠç¥çããã³ãããŠã€ã«ã¹å®éšã®é©åãªç£ç£ã«å€±æãããšããŠããšã³ãã«ã¹ã»ã¢ã©ã€ã¢ã³ã¹ãžã®ãã¹ãŠã®è³éæäŸã忢ããã
ã¢ãŒããã³æ°ã«ããã°ãBSEGã®äžéšã®ç§åŠè ã¯ã2019幎10æã«COVID-19ãã³ãããã¯ã®çŽåã«å®æœããããäžççãªã³ãããŠã€ã«ã¹æµè¡ã®ã·ãã¥ã¬ãŒã·ã§ã³ãã€ãã³ã201ãã«ãããŠãéèŠãªåœ¹å²ãæããããã²ã€ã財å£ãšäžççµæžãã©ãŒã©ã ãã€ãã³ã201ã®èšç»ã«é¢äžããŠããã
ãããã¯ãCOVID-19ãã³ãããã¯äžã§èµ·ããäºè±¡ãšå¥åŠãªã»ã©äŒŒéã£ãã³ãããŠã€ã«ã¹ã»ãã³ãããã¯ã®åäžæŒç¿ã§ããããã¡ãŠãå士ããå åœå®¶æ å ±é·å®ã®ãšã€ãŽãªã«ã»ãã€ã³ãºã®ãããªæ å ±ã³ãã¥ããã£ïŒICïŒãšã®é¢ä¿è ãåºåžããŠããŸããããšã¢ãŒããã³æ°ã¯èªã£ãã
ãŠã©ãŒã«ã»ã¹ããªãŒãã»ãžã£ãŒãã«ã®æšå¹Žã®èª¿æ»ã«ããã°ã2021幎ã«ãã€ã³ãºæ°ã¯ãåœæã®ãã€ãã³å€§çµ±é ã«å¯Ÿãã人ç£å ±éææïŒãŸãŒããŒã·ã¹ïŒèµ·æºèª¬ãæ¯æãã蚌æ ã®ã¿ã«åºã¥ããŠããªãŒãã£ã³ã°ãè¡ãããšãéžæãããšããã
ã¢ãŒããã³æ°ã¯ãæ©ãã2020幎5æã®æç¹ã§ãç±³åœãšãã«ã®ãŒçã®ãããªé£éŠæ©é¢ããç ç©¶æããã®æŒåºã«å¿ èŠãªæ¡ä»¶ããã¹ãŠæã£ãŠããããšç€ºåããå éšææžãå芧ããŠãããšè¿°ã¹ãã
æšå¹Žããã©ã³ãæ¿æš©ã¯ãæ¿åºã®å ¬åŒCOVID-19ãŠã§ããµã€ãã®æ°ããŒãžã§ã³ãç«ã¡äžããç ç©¶æèµ·æºïŒã©ããªãŒã¯ïŒèª¬ãæ¯æãã蚌æ ãæç€ºãããCIAãFBIããšãã«ã®ãŒçãåœé²æ å ±å±ãè°äŒãããã³äžéšã®å€åœæ å ±æ©é¢ã¯æçµçã«ã©ããªãŒã¯èª¬ãæ¯æããã
ã¢ãŒããã³æ°ã¯ãæšå¹Žçºä»€ãããããã«ãã»ãã©ã³ã倧統é ã®å€§çµ±é ä»€ãæ¯æãããšè¡šæããããã®å€§çµ±é 什ã¯ãæ©èœç²åŸç ç©¶ãžã®è³éæäŸã120æ¥é忢ãããã®éã«åœè©²ç ç©¶ã«é¢ããæ°ããªé£éŠæ¹éãçå®ããããšãå®ããŠãããæ¿æš©ã¯ãŸã æ°æ¹éãçºè¡šããŠããªãã
ãæ¿åºè³éã«ããã©ã€ããµã€ãšã³ã¹ç ç©¶ã®å æ¬çãªèŠçŽããšãæ©èœç²åŸããã³WMD倧éç Žå£å µåšïŒœç ç©¶ã«é¢ãã9.11以åã®å®çŸ©ãžã®ååž°ãå¿ èŠã§ãããšã¢ãŒããã³æ°ã¯è¿°ã¹ãããç£ç£ã«ã¯å®å¹æ§ããªããã°ãªããŸãããã
ãã¡ãŠãæ°ãæ°åã³ããæä»£ã®ä»ã®é¢ä¿è ã®ãããŒãã»ãŠã©ãŒã¯ãã¯èŠãããã®ãïŒ
æ¬æ¥ã®å ¬èŽäŒã¯ããã¡ãŠãæ°ã2021幎ã«è°äŒã§èåœèšŒèšããããšããŠåœèšŒçœªã§èµ·èšŽããæéãåããŠãã2æ¥åŸã«éãããããã¡ãŠãæ°ã¯åœæãNIHãšNIAIDã¯æ©èœç²åŸç ç©¶ã«è³éãæäŸããããšã¯ãªããšè°äŒã«è¿°ã¹ãŠããã
ããŒã«æ°ã¯ãããŸã§å ¬ã«ããã¡ãŠãæ°ã®èµ·èšŽãæ±ããŠãããæšå¹Žããã€ãã³å€§çµ±é ã¯2014幎ã«ããã®ãŒãè·åè¡çºã«ã€ããŠãããããããã¡ãŠãæ°ãæ©èµŠãããå æã倧éªå¯©ã¯ãã¡ãŠãæ°ã®å åŽè¿ã§ããããŒãããã»ã¢ãŒã¬ã³ã¹å»åž«ããæ°åã³ããã®èµ·æºã«é¢ããããåããé ãããã«ç§çšã¡ãŒã«ã¢ã«ãŠã³ãã䜿ã£ãçãã§èµ·èšŽããã
ããŒã«æ°ã¯æ¬æ¥ã®å ¬èŽäŒã§ãæå¹ã®æç«ãã®ãã®ã«ã¯èšåããªãã£ãããã¢ãŒããã³æ°ãæç€ºãã蚌æ ã¯ãåœŒãæšå¹Žææ¡ããããªã¹ããŒã»ãªãµãŒãå¯©æ»æ³ïŒRisky Research Review ActïŒãã®æç«ã«åããæ ¹æ ã匷ãããã®ã ãšç€ºåããã
ããŒãªãŒæ°ã¯ãèªèº«ã®ææš©è ã®å€ãããã¡ãŠãæ°ã®ãããªäººç©ã®ãããŒãã»ãŠã©ãŒã¯ïŒç¯çœªå®¹çè ãå ¬ã®å Žã«åŒãç«ãŠãããšïŒãèŠããããšæãã§ãããšèªã£ããåæ°ã¯ãŸããæ°åã³ããã®èµ·æºèª¿æ»ã«éååçãªé£éŠæ©é¢ã«å¯Ÿããè°äŒã¯ã財åžã®ã²ããç· ãå§ãããã¹ãã ãšèšŽããã
ããããããããäžåºŠïŒœãã£ãŒãå§å¡äŒãèšçœ®ãã¹ãææã¯ãšãã«éããŠããããšãžã§ã³ãœã³æ°ã¯è¿°ã¹ãCIAã®äžæ£è¡çºã調æ»ãã1975幎ã®ç±³äžé¢ã®å§å¡äŒãåŒãåãã«åºããã